- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Basilea Pharmaceutica AG (BSLN)Basilea Pharmaceutica AG stock price live, this page displays SIX BSLN stock exchange data. View the BSLN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Basilea Pharmaceutica AG real time stock price chart below.
What Is the Basilea Pharmaceutica AG Stock Price Today?
The Basilea Pharmaceutica AG stock price today is 39.85.
What Is the Stock Symbol for Basilea Pharmaceutica AG?
The stock symbol for Basilea Pharmaceutica AG is "BSLN."
What Stock Exchange Does Basilea Pharmaceutica AG Trade On?
Basilea Pharmaceutica AG is listed and trades on the Switzerland stock exchange.
Is Basilea Pharmaceutica AG a Good Stock to Buy?
Determining whether Basilea Pharmaceutica AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSLN quote. (ISIN: CH0011432447)
What Is the Basilea Pharmaceutica AG Stock Price Today?
The Basilea Pharmaceutica AG stock price today is 39.85.
What Is the Stock Symbol for Basilea Pharmaceutica AG?
The stock symbol for Basilea Pharmaceutica AG is "BSLN."
What Stock Exchange Does Basilea Pharmaceutica AG Trade On?
Basilea Pharmaceutica AG is listed and trades on the Switzerland stock exchange.
Is Basilea Pharmaceutica AG a Good Stock to Buy?
Determining whether Basilea Pharmaceutica AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSLN quote. (ISIN: CH0011432447)
39.85
-1.05(-2.57%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.80
41.00
52 wk Range
32.00
47.95
BSLN Scorecard
Full Analysis
High shareholder yield
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.8041.00
52 wk Range
32.0047.95
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockBSLN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
77.25
Upside
+93.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Basilea Pharmaceutica AG Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.
Compare BSLN to Peers and Sector
Metrics to compare | BSLN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSLNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −760.4x | −0.9x | −0.7x | |
PEG Ratio | 7.35 | 0.00 | 0.00 | |
Price/Book | 29.5x | 1.5x | 2.6x | |
Price / LTM Sales | 3.3x | 6.6x | 3.2x | |
Upside (Analyst Target) | 66.3% | 51.6% | 46.4% | |
Fair Value Upside | Unlock | 10.1% | 6.9% | Unlock |
Analysts' Recommendations
4 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 77.25
(+93.85% Upside)
People Also Watch
FAQ
What Is the Basilea Pharmaceutica AG (BSLN) Stock Price Today?
The Basilea Pharmaceutica AG stock price today is 39.85
What Stock Exchange Does Basilea Pharmaceutica AG Trade On?
Basilea Pharmaceutica AG is listed and trades on the Switzerland stock exchange.
What Is the Stock Symbol for Basilea Pharmaceutica AG?
The stock symbol for Basilea Pharmaceutica AG is "BSLN."
What Is the Basilea Pharmaceutica AG Market Cap?
As of today, Basilea Pharmaceutica AG market cap is 486.06M.
What is Basilea Pharmaceutica AG Earnings Per Share?
The Basilea Pharmaceutica AG EPS is -0.054.
What Is the Next Basilea Pharmaceutica AG Earnings Date?
Basilea Pharmaceutica AG will release its next earnings report on 17 Feb 2025.
From a Technical Analysis Perspective, Is BSLN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.